These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25882391)

  • 41. Subclinical autism spectrum symptoms in pediatric obsessive-compulsive disorder.
    Arildskov TW; Højgaard DR; Skarphedinsson G; Thomsen PH; Ivarsson T; Weidle B; Melin KH; Hybel KA
    Eur Child Adolesc Psychiatry; 2016 Jul; 25(7):711-23. PubMed ID: 26518580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Associations of obsessive-compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness.
    Kim SW; Jeong BO; Kim JM; Shin IS; Hwang MY; Paul Amminger G; Nelson B; Berk M; McGorry P; Yoon JS
    Psychiatry Res; 2015 Mar; 226(1):368-75. PubMed ID: 25681006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Montefiore-Einstein Rigidity Scale-Revised (MERS-R): Development, administration, reliability, and validity in child and adult Autism Spectrum Disorder (ASD).
    Taylor BP; Liu J; Mowrey W; Eule E; Bolognani F; Hollander E
    J Psychiatr Res; 2022 Mar; 147():142-147. PubMed ID: 35032947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [An experience of the application of rispolept in childhood schizophrenia].
    Kozlova IA; Burelomova IV; Goriunov AV; Grebchenko IuF; Masikhina SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(7):35-8. PubMed ID: 11523392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interrater reliability and clinical efficacy of Children's Yale-Brown Obsessive-Compulsive Scale in an outpatient setting.
    Yucelen AG; Rodopman-Arman A; Topcuoglu V; Yazgan MY; Fisek G
    Compr Psychiatry; 2006; 47(1):48-53. PubMed ID: 16324902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity for use among 5 to 8 year olds with obsessive-compulsive disorder.
    Freeman J; Flessner CA; Garcia A
    J Abnorm Child Psychol; 2011 Aug; 39(6):877-83. PubMed ID: 21340599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.
    Maher AR; Maglione M; Bagley S; Suttorp M; Hu JH; Ewing B; Wang Z; Timmer M; Sultzer D; Shekelle PG
    JAMA; 2011 Sep; 306(12):1359-69. PubMed ID: 21954480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients.
    Scheltema Beduin AA; Swets M; Machielsen M; Korver N;
    J Clin Psychiatry; 2012 Nov; 73(11):1395-402. PubMed ID: 23218156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale.
    Storch EA; Murphy TK; Geffken GR; Soto O; Sajid M; Allen P; Roberti JW; Killiany EM; Goodman WK
    Psychiatry Res; 2004 Nov; 129(1):91-8. PubMed ID: 15572188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study.
    Bruggeman R; van der Linden C; Buitelaar JK; Gericke GS; Hawkridge SM; Temlett JA
    J Clin Psychiatry; 2001 Jan; 62(1):50-6. PubMed ID: 11235929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and psychometric evaluation of the Mandarin Chinese version of the Yale-Brown Obsessive-Compulsive Scale - Second Edition.
    Zhang CC; Gong H; Zhang Y; Jin H; Yang Y; Li B; Li Y; Luo X; Liu W; Fang F; Li B; Sun B; Fletcher T; La Buissonnière-Ariza V; Goodman WK; Storch EA
    Braz J Psychiatry; 2019; 41(6):494-498. PubMed ID: 30785537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.
    Rosario-Campos MC; Miguel EC; Quatrano S; Chacon P; Ferrao Y; Findley D; Katsovich L; Scahill L; King RA; Woody SR; Tolin D; Hollander E; Kano Y; Leckman JF
    Mol Psychiatry; 2006 May; 11(5):495-504. PubMed ID: 16432526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Obsessive-Compulsive Disorder in Autism Spectrum Disorder Across the Lifespan.
    Pazuniak M; Pekrul SR
    Child Adolesc Psychiatr Clin N Am; 2020 Apr; 29(2):419-432. PubMed ID: 32169271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autism spectrum traits in children and adolescents with obsessive-compulsive disorder (OCD).
    Ivarsson T; Melin K
    J Anxiety Disord; 2008 Aug; 22(6):969-78. PubMed ID: 18053683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychometric properties of the obsessive compulsive inventory: child version in children and adolescents with obsessive-compulsive disorder.
    Jones AM; De Nadai AS; Arnold EB; McGuire JF; Lewin AB; Murphy TK; Storch EA
    Child Psychiatry Hum Dev; 2013 Feb; 44(1):137-51. PubMed ID: 22711294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Obsessive-Compulsive Symptom (OCS) scale of the Child Behavior Checklist: a comparison between Swedish children with Obsessive-Compulsive Disorder from a specialized unit, regular outpatients and a school sample.
    Ivarsson T; Larsson B
    J Anxiety Disord; 2008 Oct; 22(7):1172-9. PubMed ID: 18280696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial.
    DeVane CL; Charles JM; Abramson RK; Williams JE; Carpenter LA; Raven S; Gwynette F; Stuck CA; Geesey ME; Bradley C; Donovan JL; Hall AG; Sherk ST; Powers NR; Spratt E; Kinsman A; Kruesi MJ; Bragg JE
    Pharmacotherapy; 2019 Jun; 39(6):626-635. PubMed ID: 31063671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Felt but not seen: Observed restricted repetitive behaviors are associated with self-report-but not parent-report-obsessive-compulsive disorder symptoms in youth with autism spectrum disorder.
    Santore LA; Gerber A; Gioia AN; Bianchi R; Talledo F; Peris TS; Lerner MD
    Autism; 2020 May; 24(4):983-994. PubMed ID: 32168988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Demographic and clinical features of obsessive-compulsive disorder in children and adolescents.
    Hanna GL
    J Am Acad Child Adolesc Psychiatry; 1995 Jan; 34(1):19-27. PubMed ID: 7860451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 12-week, placebo-controlled trial of add-on riluzole in the treatment of childhood-onset obsessive-compulsive disorder.
    Grant PJ; Joseph LA; Farmer CA; Luckenbaugh DA; Lougee LC; Zarate CA; Swedo SE
    Neuropsychopharmacology; 2014 May; 39(6):1453-9. PubMed ID: 24356715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.